Researchers at the University Hospital of Bonn and the University of Bonn say they have dramatically rejuvenated human cells in the laboratory — including blood cells from an 80-year-old donor, which became stem cells whose molecular age read as under 20 years.
According to the university's announcement and Medical Xpress, the approach combines what the team calls protracted fate acquisition with epigenetic de-aging: rather than a single rapid reset, the cells are guided toward a new identity over time while age-related chemical marks on their DNA are wound back. The university says the rejuvenated cells can then be steered toward particular cell types, including neural cells, pointing toward patient-specific replacement tissue.
The claim matters because cellular age is not fixed. Epigenetic clocks — chemical timestamps on DNA — can be reversed in the lab, and the Bonn result suggests the reset can survive the transition into a specialised cell type, not only persist in an embryonic-like state.
Context is essential. This is test-tube biology: no clinical trial has been announced and no timeline offered, and the leap from rejuvenated cells to rejuvenated patients remains exactly that. As a demonstration that a donor's age need not limit the starting material, however, it is a notable result.
